跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Gray Chris J.
Associate Professor
Dalhousie University
,
Arts and Humanities
电子邮件
GC140200
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=55503140200
h-index
h10-index
h5-index
2385
引用
14
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
625
引用
13
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
56
引用
5
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2010
2023
每年的科研成果
综述
指纹
网络
科研成果
(35)
新闻 / 媒体
(2)
相似简介
(6)
指纹
深入其中 Gray Chris J. 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Ablation Therapy
12%
Adenosine
14%
Ambulatory Care
25%
Antiarrhythmic Agent
30%
Arrhythmogenic Right Ventricular Dysplasia
14%
Atrial Fibrillation
71%
Blood Pressure
14%
Cardiac Electrophysiology
14%
Cardiac Resynchronization Therapy
16%
Cardiovascular System
18%
Catheter Ablation
69%
Catheter Ablation
46%
Coronary Artery Disease
6%
Cost-Effectiveness Analysis
20%
Device Therapy
16%
DNA Template
14%
Drug Therapy
24%
Ejection Fraction
6%
Electrography
12%
Electrophysiology
16%
Emergency Department
9%
Endocardium
13%
Gene Mutation
14%
Hazard Ratio
37%
Health Care Cost
26%
Heart Failure
32%
Heart Left Ventricle Ejection Fraction
11%
Heart Muscle Revascularization
14%
Heart Rehabilitation
14%
Heart Ventricle Arrhythmia
40%
Implantable Automatic Defibrillator
75%
Ischemic Cardiomyopathy
18%
Odds Ratio
10%
P Wave
14%
Patient Referral
28%
Pressure Control
14%
Prevalence
14%
Primary Prevention
61%
Pulmonary Vein Isolation
14%
Quality Adjusted Life Year
11%
Quality of Life
8%
Recurrent Disease
28%
Retrospective Cohort Study
15%
Revascularization
7%
Rural Population
14%
Shock (Circulatory)
26%
Sudden Cardiac Death
30%
Supraventricular Tachycardia
14%
Tertiary Care
7%
Ventricular Tachycardia
100%
Keyphrases
Ablation
9%
Ablation Outcomes
7%
Access Roads
14%
Ambulatory Care
14%
Antiarrhythmic Therapy
14%
Atrial Fibrillation
28%
Atrial Fibrillation Clinics
25%
Blood Pressure Treatment
10%
Bundle Branches
14%
Cardiac Implantable Electronic Device Complications
14%
Cardiac Resynchronization Therapy
14%
Conduction Recovery
8%
Confidence Interval
34%
Cost-effectiveness
25%
Cost-utility Analysis
14%
Drug Therapy
11%
Focal Atrial Tachycardia
10%
Hazard Ratio
17%
Heart Failure
28%
Heart Failure Hospitalization
18%
Implantable Cardioverter-defibrillator Shock
15%
Implantable Defibrillator
28%
Inappropriate ICD Therapy
14%
Integrated Management
28%
Ischemic Scar
14%
Left Ventricular Ejection Fraction
8%
Lesion Formation
8%
Life-threatening Arrhythmias
14%
Localization System
11%
LQT1
14%
Nova Scotia
7%
Optimal Force
14%
P-wave Morphology
14%
Population-based Cohort
14%
Primary Prevention
18%
Probabilistic Analysis
7%
Quality-adjusted Life Years
20%
Reentrant Ventricular Tachycardia
14%
Refractory Ventricular Tachycardia
19%
Septal Pacing
14%
Shock
14%
Shock Hazard
7%
Site Localization
8%
Sudden Cardiac Death Prevention
28%
Survival Benefit
14%
TMEM43
14%
Usual Care
10%
Ventricular Tachycardia Ablation
14%
Ventriculoatrial Conduction
14%
Virtual Platform
14%
